Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Standard Biotools (LAB) FCF Margin (2016 - 2025)

Historic FCF Margin for Standard Biotools (LAB) over the last 17 years, with Q3 2025 value amounting to 118.09%.

  • Standard Biotools' FCF Margin rose 183100.0% to 118.09% in Q3 2025 from the same period last year, while for Sep 2025 it was 51.72%, marking a year-over-year increase of 738100.0%. This contributed to the annual value of 87.03% for FY2024, which is 436600.0% down from last year.
  • As of Q3 2025, Standard Biotools' FCF Margin stood at 118.09%, which was up 183100.0% from 103.64% recorded in Q2 2025.
  • In the past 5 years, Standard Biotools' FCF Margin registered a high of 16.12% during Q4 2024, and its lowest value of 182.23% during Q2 2024.
  • In the last 5 years, Standard Biotools' FCF Margin had a median value of 62.1% in 2022 and averaged 80.88%.
  • Its FCF Margin has fluctuated over the past 5 years, first surged by 1279500bps in 2023, then tumbled by -1454800bps in 2024.
  • Standard Biotools' FCF Margin (Quarter) stood at 19.51% in 2021, then plummeted by -278bps to 73.78% in 2022, then soared by 32bps to 50.16% in 2023, then soared by 68bps to 16.12% in 2024, then tumbled by -633bps to 118.09% in 2025.
  • Its FCF Margin was 118.09% in Q3 2025, compared to 103.64% in Q2 2025 and 86.62% in Q1 2025.